Feedback (LON:FDBK) Insider Emma Oswick (Stuart) Acquires 60,459 Shares

December 24, 2025 by InsiderTrades.com

Key Points

Emma Oswick (Stuart) purchased 60,459 shares on December 23 at an average price of GBX 8 per share, for a total of about £4,836.72.
Feedback trades around GBX 8.30 (1‑year low GBX 7.50, high GBX 21.40) and has a market cap of £3.64 million with a negative P/E of -0.33, signalling a small, loss-making company trading near recent lows.
Feedback plc (via Feedback Medical) offers healthcare IT solutions, notably the regulated Bleepa® platform that links clinical systems to share diagnostics and streamline patient pathways.

Feedback plc (LON:FDBK - Get Free Report) insider Emma Oswick (Stuart) bought 60,459 shares of the stock in a transaction dated Tuesday, December 23rd. The stock was purchased at an average price of GBX 8 per share, with a total value of £4,836.72.

Feedback Price Performance

Shares of LON FDBK opened at GBX 8.30 on Wednesday. Feedback plc has a 1 year low of GBX 7.50 and a 1 year high of GBX 21.40. The firm has a 50-day simple moving average of GBX 8.50 and a two-hundred day simple moving average of GBX 11.53. The company has a market cap of £3.64 million, a P/E ratio of -0.33 and a beta of 0.77.

About Feedback

(Get Free Report)

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical. Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients. By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers. Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Feedback?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Feedback and related companies.

From Our Partners